The company is developing a drug to treat traumatic brain injury using a molecule extracted from marine macroalgae. This molecule targets the immune system to promote repair after brain trauma. The therapy aims to reduce stimulate the immune cells and enhance neurological recovery. We also work to valorise extraction by-products, ensuring a sustainable, biotech-driven approach to neurorepair. Expertise is sought in polysaccharide chemistry and extraction of molecules at pharmaceutical grade.
Ref. BRLV20250722013 Empresa letona busca fabricantes europeos de equipos industriales y soluciones de automatización para representarlos en el Báltico y/o Escandinavia.
A Latvian company specialised in industrial equipment and automation is looking for innovative manufacturers from Europe or Asia to represent in the Baltics and/or Scandinavia. The company is active in plastics processing, packaging, food, metal, textile, printing,...
Jul 25, 2025